Table 1 The clinical characteristics of the182 patients of DLBCL
From: Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
Characteristics | No. of cases (%) |
|---|---|
Age (years) | |
≤ 60 | 114 (62.6) |
Male | 110 (60.4) |
Stage III-IV | 111 (61.0) |
Elevated ESR | 61 (33.5) |
Elevated LDH | 84 (46.2) |
ECOG PS ≥ 2 | 30 (16.5) |
ENI ≥ 2 | 45 (24.7) |
IPI score of 3–5 | 49 (26.9) |
B symptoms | 85 (46.7) |
COO (Hans) | |
GCB | 73 (40.1) |